Genesis Biopharma Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
Analyze the public filings of asset managers
Dive into the EDGAR, IAPD, CAFR source data
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Genesis Biopharma Inc
TickerIOVA
CIK #0001425205
CUSIP462260100
SectorEnergy & Transportation - Arrangement Of Transportation Of Freight & Cargo
Address1601 N Sepulveda Blvd, #632, Manhattan Beach, CA 90266
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Lion Biotechnologies Inc 2016-06-15 100.0 M Exemption: 506(b) · Duration: One year or less · Commission: $4,000,000 · Revenue: No Revenues
Genesis Biopharma Inc 2013-06-06 1.4 M Exemption: 506 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001425205] 10-K
[0001425205] 10-Q
[0001425205] 3
[0001425205] 4
[0001425205] 5
[0001425205] 8-K
[0001425205] D
[0001425205] SC 13D
[0001425205] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Iovance Biotherapeutics Inc [2026-05-12] 0.0
State Street Corp Iovance Biotherapeutics Inc [2026-02-09] 0.0
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2024-03-01] 81946.9
Point72 Asset Management LP Iovance Biotherapeutics Inc [2023-02-17] 4.6
BlackRock Inc Iovance Biotherapeutics Inc [2023-02-03] 7.7
State Street Corp Iovance Biotherapeutics Inc [2023-02-02] 9.32
MHR Fund Management LLC Iovance Biotherapeutics Inc [2022-12-30] 5.8
Wellington Management Group LLP Iovance Biotherapeutics Inc [2022-02-04] 6.11
Ark Investment Management LLC Iovance Biotherapeutics Inc [2021-01-11] 10.43
Price T Rowe Associates Inc /MD/ Iovance Biotherapeutics Inc [2020-02-14] 5.1
Vanguard Group Inc Iovance Biotherapeutics Inc [2020-02-11] 8.6
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2019-02-14] 9.9
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2019-02-14] 2.5
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2018-02-14] 5.4
Broadfin Capital LLC Iovance Biotherapeutics Inc [2018-02-13] 6.75
BlackRock Inc Iovance Biotherapeutics Inc [2018-01-25] 6.7
OrbiMed Advisors LLC Lion Biotechnologies Inc [2017-02-13] 3.92
Acuta Capital Partners LLC Lion Biotechnologies Inc [2017-02-13] 6.1
Franklin Resources Inc Lion Biotechnologies Inc [2017-02-07] 8.4
Quogue Capital LLC Lion Biotechnologies Inc [2016-06-13] 0.6
venBio Select Advisor LLC Lion Biotechnologies Inc [2016-02-12] 6.7
RS Investment Management Co LLC Lion Biotechnologies Inc [2016-02-12] 5.55
Broadfin Capital LLC Lion Biotechnologies Inc [2016-02-11] 7.31
BlackRock Inc Lion Biotechnologies Inc [2016-01-28] 6.6
Perceptive Advisors LLC Lion Biotechnologies Inc [2015-02-17] 0.76
FMR LLC Lion Biotechnologies Inc [2014-07-10] 0.0
Alpha Capital Anstalt Lion Biotechnologies Inc [2014-01-02] 7.197
Ayer Capital Management LP Genesis Biopharma Inc [2013-06-03] 40.47
[2013-01-09] None
Form 3/4/5 Filer 2011 - 2026
Puri Raj K
Iovance Biotherapeutics Inc
Maynard Ryan D
Countouriotis Athena
Dukes Iain D
Weiser Michael
Vogt Frederick G
Graf Finckenstein Friedrich
Bilinsky IGOR
Kirby Daniel Gordon
Roche Corleen M
Rosinack Matthew W
Yarno Wendy L
Bellemin Jean-Marc
Rothbaum Wayne P
McPeak Merrill A
Dixon Wendy L
Swartzburg Michael
Fardis Maria
Morris Timothy E
Venkatesan Jay
Hillsberg Sanford
Valle Franco
Schiffman Gregory T
Henderson Molly
Fischkoff Steven A
Lotze Michael
Hawkins ELMA
Bender James G
ACM Capital Partners LLC
Ayer Capital Management LP
Ayer Capital Partners LLC
Radvanyi Laszlo
Handelman Michael D
Bristol Investment Fund Ltd
Bristol Capital LLC
Singh Manish
Voyticky David J
Kessler Paul L
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Graf Finckenstein Friedrich
Restricted Stock Units · derivative
2026-03-09 Grant 58,750 $0.00
Roche Corleen M
Restricted Stock Units · derivative
2026-03-09 Grant 132,200 $0.00
Bilinsky IGOR
Restricted Stock Units · derivative
2026-03-09 Grant 117,500 $0.00
Kirby Daniel Gordon
Restricted Stock Units · derivative
2026-03-09 Grant 132,200 $0.00
Puri Raj K
Restricted Stock Units · derivative
2026-03-09 Grant 117,500 $0.00
Vogt Frederick G
Restricted Stock Units · derivative
2026-03-09 Grant 235,000 $0.00
Graf Finckenstein Friedrich
Common Stock
2026-03-05 Tax withheld 16,520 $4.58 75,662
Bilinsky IGOR
Common Stock
2026-03-05 Tax withheld 16,628 $4.58 76,156
Graf Finckenstein Friedrich
Common Stock
2026-03-05 Option exercise 31,246 $0.00
Puri Raj K
Restricted Stock Units · derivative
2026-03-05 Option exercise 39,059 $0.00
Puri Raj K
Common Stock
2026-03-05 Option exercise 39,059 $0.00
Vogt Frederick G
Restricted Stock Units · derivative
2026-03-05 Option exercise 62,493 $0.00
Puri Raj K
Common Stock
2026-03-05 Tax withheld 18,360 $4.58 84,089
Bilinsky IGOR
Common Stock
2026-03-05 Option exercise 31,246 $0.00
Vogt Frederick G
Common Stock
2026-03-05 Option exercise 62,493 $0.00
Graf Finckenstein Friedrich
Restricted Stock Units · derivative
2026-03-05 Option exercise 31,246 $0.00
Vogt Frederick G
Common Stock
2026-03-05 Tax withheld 26,755 $4.58 122,538
Bilinsky IGOR
Restricted Stock Units · derivative
2026-03-05 Option exercise 31,246 $0.00
Vogt Frederick G
Common Stock
2026-03-02 Tax withheld 22,809 $3.79 86,446
Vogt Frederick G
Restricted Stock Units · derivative
2026-03-02 Option exercise 10,418 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 289 268,989,087
2025-12-31 264 261,535,225
2025-09-30 254 217,679,935
2025-06-30 252 224,472,430
2025-03-31 305 236,919,137
2024-12-31 307 238,802,290
2024-09-30 292 233,637,547
2024-06-30 300 232,679,220
2024-03-31 284 224,545,530
2023-12-31 244 216,931,206
2023-09-30 233 217,557,698
2023-06-30 223 201,009,581
Form 13F Holdings
Firm Period DFND Voting Shares
Mirador Capital Partners LP [2026-06-30] SOLE 1,080,288 1,080,288
Hennion & Walsh Asset Management Inc [2026-06-30] SOLE 818,913 818,913
TEMA ETFS LLC [2026-06-30] SOLE 280,048 280,048
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 5,290 102,018
Centurion Wealth Management LLC [2026-06-30] SOLE 0 69,168
B Riley Wealth Advisors Inc [2026-06-30] SOLE 51,000 51,000
Assenagon Asset Management SA [2026-06-30] SOLE 46,842 46,842
Traphagen Investment Advisors LLC [2026-06-30] SOLE 0 38,962
Grimes & Company Inc [2026-06-30] SOLE 18,021 37,842
Sequoia Financial Advisors LLC [2026-06-30] SOLE 0 32,957
Brookstone Capital Management [2026-06-30] SOLE 0 22,607
Merit Financial Group LLC [2026-06-30] OTR 0 15,587
NorthCrest Asset Manangement LLC [2026-06-30] SOLE 890 13,028
Merit Financial Group LLC [2026-06-30] SOLE 55 9,249
Farther Finance Advisors LLC [2026-06-30] SOLE 0 7,093
Gamma Investing LLC [2026-06-30] DFND 5,422 5,422
Wealth Enhancement Trust Services Inc [2026-06-30] DFND 4,000 4,000
IFP Advisors LLC [2026-06-30] SOLE 1,611 1,611
First United Bank & Trust [2026-06-30] SOLE 1,000 1,000
True Wealth Design LLC [2026-06-30] SOLE 0 400
LRI Investments LLC [2026-06-30] SOLE 209 209
Fortitude Family Office LLC [2026-06-30] SOLE 61 61
FNY Investment Advisers LLC [2026-06-30] SOLE 6,000 5
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com